Influenza Home Testing Market

Influenza Home Testing Market : Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031

Market Overview

According to the latest research by Future Market Insights, Influenza Home Testing Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031. The influenza home testing will show growth due to the rising prevalence of influenza globally and an increase in investment to develop at-home influenza testing kits. Therefore, growth at a significantly high CAGR will be expected soon.

What is driving the Demand for Influenza Home Testing?

The rising prevalence of Influenza across the globe, increase in per capita healthcare expenditure is driving the demand for home influenza testing. Increasing is government initiatives to develop over-the-counter influenza A and B virus’s diagnostic tests are creating huge opportunities in the Influenza Home Testing market.

For instance, In 2018, According to the Department of Health and Human Services (HHS) of the U.S., Biomedical Advanced Research and Development Authority (BARDA) is associating with Cue Health Inc., and Diassess Inc., to improve first-in-class influenza testing devices, BARDA has provided $14 million to Cue Health and $10 million to Diassess for advanced development of diagnostic tests for influenza A and B viruses that are being developed for purchase over-the-counter influenza home testing.

Also, with increasing demand in the field of diagnosis, the major players and different countries made advances in their research and technology for making the process easy, painless and rapid. All these factors drive the Influenza Home Testing Market significantly during the forecast period from 2021 to 2031.

COVID-19 Likely to Propel the Growth of Influenza Home Testing Market

With the outbreak of COVID-19, the world started following social distancing. Social distancing is the most important factor for dropping the cases of COVID-19 and breaking the chain of the virus. The disease spread at a very rate through sneezing, talking, coughing, singing etc. from one person to another person. So, in the age of social distancing influenza, home testing provides safety to both patients and healthcare providers. Patients don’t need to visit the hospital, diagnostic centre or clinic for influenza testing.

The confirmed cases of COVID-19 reached 167,252,150 on 25th May 2021 in less than two years according to WHO. Therefore, it has been concluded that COVID-19 propels the influenza home testing market during the forecast period.

The U.S. and Canada Influenza Home Testing Market Outlook

 U.S. and Canada will retain the top position in the market of influenza home testing due to the rising prevalence of influenza in the region and increasing adoption of home testing kits.

According to the Centers for Disease Control and Prevention (CDC), In the U.S. influenza infections cause more than 200,000 hospitalizations and 36,000 deaths every year. In adults, bronchitis and pneumonia are the most common problems of influenza.

The geriatric population with heart and lung disease, and immunocompromised patients such as cancer patients or those with HIV infection and transplant patients, etc. are mainly prone to influenza which need to be diagnosed as early as possible to reduce risk. The diagnostic of influenza is growing as peoples are becoming aware of viral diseases such as influenza. Thus need for home influenza testing is increased significantly.

Europe Demand Outlook for Influenza Home Testing

Europe was hit badly by the corvid-19 pandemic in 2020. This makes them focus primarily on their healthcare sector and developing new technologies and adopting new devices for minimizing the discomfort of the population.

According to WHO, 54,147,639 confirmed cases of covid-19 was recorded till 25th May 2021in Europe. This can only be controlled by vaccinations and social distancing. Therefore, it is important to adopt such methods as influenza home testing and self-testing kits to follow the social distancing and avoid gathering of people at hospitals, clinics and diagnostic labs. This will result in developing the influenza home testing demand in Europe during the forecast period.

Who are the Key Manufacturers and Suppliers of Influenza Home Testing?

Some of the leading manufacturers and suppliers of influenza home testing include

  • Quidel Corporation
  • Abbott Laboratories
  • Cardinal Health
  • Becton
  • Dickinson and Company
  • Danaher Corporation
  • Others

These companies followed certain strategies like a partnership, new product lunch and approval, merger and acquisitions to gain a good position in the market.  For instance, In 2018, Siemens Healthineers complete the acquisition of Fast Track Diagnostics Ltd., to expand their molecular diagnostics portfolio for infectious diseases.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Influenza Home Testing Market? Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key Segments

By Test Type:

  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • TMA
    • LAMP
    • NASBA
    • Other
  • Others

By Indication:

  • Influenza virus A
  • Influenza virus B
  • Influenza virus C

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports


Influenza Home Testing Market